Comprehensive resource that fills a significant knowledge gap
Features the latest clinical evidence and management guidance
Chapters authored by leaders in the field
Adrian Covic, MD, PhD Full Professor of Nephrology Dialysis and Renal Transplantation Unit "C. I. Parhon” University Hospital Iasi, Romania Mehmet Kanbay, MD Associate Professor, Department of Medicine, Division of Nephrology, Kayseri Training and Research Hospital, Melikgazi, Kayseri, Turkey EDGAR V. LERMA, MD, FACP, FASN, FAHA, FASH, FNLA, FNKF Clinical Associate Professor of Medicine Section of Nephrology Department of Medicine University of Illinois at Chicago College of Medicine/ Associates in Nephrology, S.C. Chicago, IL
Dyslipidemia in chronic kidney disease is a common clinical problem and growing in prevalence. With the recent publication of clinical practice guidelines on the management of lipid related disorders in patients affected by chronic kidney disease, an up-to-date and comprehensive resource of evidence-based literature is needed. Dyslipidemias in Kidney Disease captures the growing body of information on this subject matter. This book presents the latest clinical evidence and management guidance for patients of various demographics and stages of chronic kidney disease. Written for the nephrologist community, as well as cardiologists and general practitioners, this guide will provide practical knowledge and fill a much needed void in the literature.
Prevalence of dyslipidemia in general and in the CKD patient.- Lipid Nephrotoxicity: New Concept for an Old Disease.- Hyperlipidemia a risk factor or protective for progression of CKD in nondibetics.- How lipid lowering agents works: The good, the bad and the ugly.- CVD in CKD - Focus on the dyslipidemia problem.- The CKD patient with dyslipidemia.- Review of Clinical Trials pertaining to dyslipidemias in CKD.- Lifestyle modifications in the management of dyslipidemias in CKD.- Lipid-Lowering Medication Does Adjustments for Reduced Kidney Function.- Non-statins therapies for CKD with dyslipidemia.- Dyslipidemia in dialysis.- Dyslipidemia in the Kidney Transplant Patient.- Dyslipidemia in the Patient with Nephrotic syndrome.- Dyslipidemias in the Pediatric CKD Patient.- Dyslipidemias in the Geriatric CKD Patient.- Dialysis modalities in dyslipidemia.- Review of current guidelines.
Dyslipidemia in chronic kidney disease is a common clinical problem and growing in prevalence. With the recent publication of clinical practice guidelines on the management of lipid related disorders in patients affected by chronic kidney disease, an up-to-date and comprehensive resource of evidence-based literature is needed. Dyslipidemias in Kidney Disease captures the growing body of information on this subject matter. This book presents the latest clinical evidence and management guidance for patients of various demographics and stages of chronic kidney disease. Written for the nephrologist community, as well as cardiologists and general practitioners, this guide will provide practical knowledge and fill a much needed void in the literature.
From the book reviews:
"This is a comprehensive book on dyslipidemias in kidney disease. ... This is an excellent tool for nephrologists, whether clinical or research oriented. It is also of great interest to internists, cardiologists, endocrinologists, and all healthcare providers who have a particular interest in lipid-related disorders. ... It is fully updated and summarizes the rapid advances made in the field of lipid disorders, with a focus on coexisting diseases within nephrology. The tables and graphs are appropriate and add meaningful information.” (Fnu Salahuddin, Doody´s Book Reviews, August, 2014)
Dyslipidemia in chronic kidney disease is a common clinical problem and growing in prevalence. With the recent publication of clinical practice guidelines on the management of lipid related disorders in patients affected by chronic kidney disease, an up-to-date and comprehensive resource of evidence-based literature is needed. Dyslipidemias in Kidney Disease captures the growing body of information on this subject matter. This book presents the latest clinical evidence and management guidance for patients of various demographics and stages of chronic kidney disease. Written for the nephrologist community, as well as cardiologists and general practitioners, this guide will provide practical knowledge and fill a much needed void in the literature.
Prevalence of dyslipidemia in general and in the CKD patient.- Lipid Nephrotoxicity: New Concept for an Old Disease.- Hyperlipidemia a risk factor or protective for progression of CKD in nondibetics.- How lipid lowering agents works: The good, the bad and the ugly.- CVD in CKD - Focus on the dyslipidemia problem.- The CKD patient with dyslipidemia.- Review of Clinical Trials pertaining to dyslipidemias in CKD.- Lifestyle modifications in the management of dyslipidemias in CKD.- Lipid-Lowering Medication Does Adjustments for Reduced Kidney Function.- Non-statins therapies for CKD with dyslipidemia.- Dyslipidemia in dialysis.- Dyslipidemia in the Kidney Transplant Patient.- Dyslipidemia in the Patient with Nephrotic syndrome.- Dyslipidemias in the Pediatric CKD Patient.- Dyslipidemias in the Geriatric CKD Patient.- Dialysis modalities in dyslipidemia.- Review of current guidelines.
From the book reviews:
"This is a comprehensive book on dyslipidemias in kidney disease. ... This is an excellent tool for nephrologists, whether clinical or research oriented. It is also of great interest to internists, cardiologists, endocrinologists, and all healthcare providers who have a particular interest in lipid-related disorders. ... It is fully updated and summarizes the rapid advances made in the field of lipid disorders, with a focus on coexisting diseases within nephrology. The tables and graphs are appropriate and add meaningful information." (Fnu Salahuddin, Doody's Book Reviews, August, 2014)
Adrian Covic, MD, PhD Full Professor of Nephrology Dialysis and Renal Transplantation Unit "C. I. Parhon" University Hospital Iasi, Romania Mehmet Kanbay, MD Associate Professor, Department of Medicine, Division of Nephrology, Kayseri Training and Research Hospital, Melikgazi, Kayseri, Turkey EDGAR V. LERMA, MD, FACP, FASN, FAHA, FASH, FNLA, FNKF Clinical Associate Professor of Medicine Section of Nephrology Department of Medicine University of Illinois at Chicago College of Medicine/ Associates in Nephrology, S.C. Chicago, IL
Über den Autor
Adrian Covic, MD, PhD Full Professor of Nephrology Dialysis and Renal Transplantation Unit "C. I. Parhon" University Hospital Iasi, Romania Mehmet Kanbay, MD Associate Professor, Department of Medicine, Division of Nephrology, Kayseri Training and Research Hospital, Melikgazi, Kayseri, Turkey EDGAR V. LERMA, MD, FACP, FASN, FAHA, FASH, FNLA, FNKF Clinical Associate Professor of Medicine Section of Nephrology Department of Medicine University of Illinois at Chicago College of Medicine/ Associates in Nephrology, S.C. Chicago, IL
Inhaltsverzeichnis
Prevalence of dyslipidemia in general and in the CKD patient.- Lipid Nephrotoxicity: New Concept for an Old Disease.- Hyperlipidemia a risk factor or protective for progression of CKD in nondibetics.- How lipid lowering agents works: The good, the bad and the ugly.- CVD in CKD - Focus on the dyslipidemia problem.- The CKD patient with dyslipidemia.- Review of Clinical Trials pertaining to dyslipidemias in CKD.- Lifestyle modifications in the management of dyslipidemias in CKD.- Lipid-Lowering Medication Does Adjustments for Reduced Kidney Function.- Non-statins therapies for CKD with dyslipidemia.- Dyslipidemia in dialysis.- Dyslipidemia in the Kidney Transplant Patient.- Dyslipidemia in the Patient with Nephrotic syndrome.- Dyslipidemias in the Pediatric CKD Patient.- Dyslipidemias in the Geriatric CKD Patient.- Dialysis modalities in dyslipidemia.- Review of current guidelines.
Klappentext
Dyslipidemia in chronic kidney disease is a common clinical problem and growing in prevalence. With the recent publication of clinical practice guidelines on the management of lipid related disorders in patients affected by chronic kidney disease, an up-to-date and comprehensive resource of evidence-based literature is needed. Dyslipidemias in Kidney Disease captures the growing body of information on this subject matter. This book presents the latest clinical evidence and management guidance for patients of various demographics and stages of chronic kidney disease. Written for the nephrologist community, as well as cardiologists and general practitioners, this guide will provide practical knowledge and fill a much needed void in the literature.
Comprehensive resource that fills a significant knowledge gap
n
Features the latest clinical evidence and management guidance
n
Chapters authored by leaders in the field
n
Includes supplementary material: sn.pub/extras
n
